Skip to content
Open access

Formononetin Protects Against Cerebral Ischemia-Reperfusion-Induced Lung Injury: Insights from Animal and Cell Models

Sep 2026 · Journal of Inflammation Research · Vol 19, pp. 1-16 · 0 citations · 39 references
Medicine

TL;DR

In vivo and in vitro studies offer new insights into the clinical application of formononetin in cerebrovascular diseases for secondary lung injury as well as protecting against lung injury by inhibiting inflammatory cytokines, reducing oxidative stress, and regulating immune cells.

Abstract

Background Cerebral ischemia-reperfusion (CIR) affects multiple organs, with lung injury being particularly prevalent. Formononetin, derived from legumes, has multiple pharmacological effects and demonstrated potential for the treatment of neurological diseases. However, its effects on CIR-induced lung injury are unknown. Objective To investigate the protective effect of formononetin in CIR-induced lung injury (in the Sprague-Dawley (SD) rats’ model). Methods Sprague-Dawley rats (n=27) underwent middle cerebral artery occlusion (MCAO) to establish a CIR model. Formononetin was then administered at specific time points. Longa neurological deficit score, histological staining, enzyme-linked immunosorbent assay (ELISA), and flow cytometry were subsequently used to assess lung injury. In addition, rat microglia were exposed to oxygen-glucose deprivation/re-oxygenation (OGD/R) to mimic CIR in vitro, and exosomes were then extracted from these cells for testing. A lipopolysaccharide (LPS)-induced lung epithelial cell injury model was subsequently used to investigate the protective effects of formononetin. Results ELISA revealed that formononetin exerted broad-spectrum anti-inflammatory effects, reducing TNF-α, IL-1β, IL-6, and IL-10 by 46.7%, 46.2%, 40.1%, and 54.6%, respectively, in bronchoalveolar lavage fluid after MCAO (P<0.05). In lung tissues, superoxide dismutase (SOD) expression was increased, while malondialdehyde (MDA) was decreased (22.8%). Additionally, formononetin reduced interferon-gamma positive (INF-γ⁺), IL-4⁺, IL-17A⁺, forkhead box P3 protein positive (Foxp3⁺), cluster of differentiation 4 positive (CD4⁺), and CD8⁺ by 72.3%, 76.7%, 66.1%, 67.7%, 78.4%, and 80.4%, respectively, all to sham levels (P < 0.05). The in vitro experiments also revealed a downward trend in the expression of inflammatory factors in lung epithelial cells, with increased SOD expression (26.2%) and decreased MDA levels (21.7%, P<0.05). Conclusion Formononetin protects against lung injury by inhibiting inflammatory cytokines, reducing oxidative stress, and regulating immune cells. Notably, exosomes derived from formononetin-treated microglia were shown to attenuate LPS-induced lung epithelial cell injury, highlighting a novel intercellular communication pathway. Together, these in vivo and in vitro studies offer new insights into the clinical application of formononetin in cerebrovascular diseases for secondary lung injury.

Read PDF

Similar papers

Open access May 2026

Barbaloin Attenuates Cerebral Ischemia and Reperfusion Injury in Rats and Inhibits Lipopolysaccharide-Stimulated Inflammatory Responses in BV2 Microglial Cells

Background: Barbaloin (BAR) is a naturally occurring bioactive anthracycline derived from the leaf exudates of aloe plants with a variety of biological and pharmacological properties. The aim of the present study was to investigate the neuroprotective effects of BAR against cerebral ischemia and reperfusion (I/R) injur...

Cai-Yun Liu, Lin Wang, Hong-Yan Ren et al. · 0 citations
Sep 2026

Echinocystic acid alleviates cerebral ischemia-reperfusion injury through PPARγ-dependent modulation of microglial polarization and pyroptotic signaling.

Findings indicate that Echinocystic acid protects against CIRI, at least in part, through a PPARγ-dependent mechanism involving promotion of microglial M2 polarization and attenuation of NLRP3/Caspase-1/GSDMD-associated pyroptotic signaling, highlighting the therapeutic potential of EA in CIRI.

Yi Zou, Hui Zhang, Jian-Xia Liu et al. · 0 citations
Open access Sep 2026

Gentiopicroside Attenuates Renal Ischemia-Reperfusion Injury through Suppression of JNK/MAPK Signaling.

BACKGROUND Renal ischemia-reperfusion injury (IRI) is a major cause of acute kidney injury (AKI) with significant clinical impact. Gentiopicroside (GPS), a natural secoiridoid glycoside isolated from traditional medicinal plants, has been reported to exert anti-inflammatory and cytoprotective activities, yet its potent...

Lan Luo, Jia Liu, Na Zhang et al. · 0 citations
Oct 2026

Intranasal administration of enalapril confers acute neuroprotection by mitigating mitochondrial dysfunction and apoptosis in a rat model of ischemic stroke.

BACKGROUND Stroke remains a leading cause of mortality and long-term disability worldwide, with effective treatments hindered by its complex pathophysiology. This study is the first to explore the neuroprotective potential of intranasal enalapril, in mitigating ischemic stroke outcomes through its influence on mitochon...

Nooshin Sadeghian, Saied Salimpour Azar, Javad Shadman et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.